Preparation of a non-immunogenic arginase by the covalent attachment of polyethylene glycol
- PMID: 454671
- DOI: 10.1016/0005-2795(79)90111-9
Preparation of a non-immunogenic arginase by the covalent attachment of polyethylene glycol
Abstract
Methoxypolyethylene glycol of 5000 daltons (PEG) was attached covalently to bovine liver arginase using 2,4,6-trichloro-s-triazine as the coupling agent. The conjugate (PEG-arginase), with PEG attached to 53% of the amino groups, retained 65% of its original enzymatic activity. Mice were injected intravenously with arginase or PEG-arginase for periods of one to three months. The blood-circulating life of PEG-arginase was greatly extended over that of arginase. The half-life of injected arginase at day 30 was less than 1 h, whereas that of the PEG-enzyme was 12 h. Antisera from mice injected with native arginase reacted against arginase but not against PEG-arginase when tested by immunodiffusion. Antisera from animals injected with PEG-arginase reacted neither with native arginase nor PEG-arginase. The data indicate that arginase modified by PEG has been rendered both non-immunogenic and non-antigenic when tested in mice. The injection of PEG-arginase into mice did not induce tolerance toward the native enzyme. Injected PEG-arginase, in the presence of precipitating antibody directed against native arginase, circulated at the same level as in virgin animals. The attachment of PEG to arginase altered its kinetic properties.
Similar articles
-
Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase.J Biol Chem. 1977 Jun 10;252(11):3582-6. J Biol Chem. 1977. PMID: 16907
-
Alteration of the circulating life and antigenic properties of bovine adenosine deaminase in mice by attachment of polyethylene glycol.Clin Exp Immunol. 1981 Dec;46(3):649-52. Clin Exp Immunol. 1981. PMID: 7337981 Free PMC article.
-
Cancer therapy with chemically modified enzymes. II. The therapeutic effectiveness of arginase, and arginase modified by the covalent attachment of polyethylene glycol, on the taper liver tumor and the L5178Y murine leukemia.Cancer Biochem Biophys. 1984 Sep;7(3):261-8. Cancer Biochem Biophys. 1984. PMID: 6488153
-
Use of site-directed mutagenesis to enhance the epitope-shielding effect of covalent modification of proteins with polyethylene glycol.Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7185-9. doi: 10.1073/pnas.88.16.7185. Proc Natl Acad Sci U S A. 1991. PMID: 1714590 Free PMC article.
-
The uses and properties of PEG-linked proteins.Crit Rev Ther Drug Carrier Syst. 1992;9(3-4):249-304. Crit Rev Ther Drug Carrier Syst. 1992. PMID: 1458545 Review.
Cited by
-
Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using Antibodies.Int J Mol Sci. 2022 Nov 11;23(22):13929. doi: 10.3390/ijms232213929. Int J Mol Sci. 2022. PMID: 36430411 Free PMC article. Review.
-
Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion.Int J Mol Sci. 2019 Nov 29;20(23):6018. doi: 10.3390/ijms20236018. Int J Mol Sci. 2019. PMID: 31795337 Free PMC article.
-
Arginase from Priestia megaterium and the Effects of CMCS Conjugation on Its Enzymological Properties.Curr Microbiol. 2023 Jul 19;80(9):292. doi: 10.1007/s00284-023-03406-w. Curr Microbiol. 2023. PMID: 37466752
-
Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery.Annu Rev Pharmacol Toxicol. 2014;54:581-98. doi: 10.1146/annurev-pharmtox-010611-134615. Epub 2013 Oct 23. Annu Rev Pharmacol Toxicol. 2014. PMID: 24160695 Free PMC article. Review.
-
Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies.Cancer Immunol Immunother. 2007 Mar;56(3):303-317. doi: 10.1007/s00262-006-0180-4. Cancer Immunol Immunother. 2007. PMID: 16738850 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources